Dario Health Corp.Stock on Buying mode .
Target price above 1.000 $
Harmonic shap (( anti Crap )) .
Buy it 🔥
DRIO trade ideas
DRIO TTM_Squeeze -7.6 and Heading upMACD, RSI, MFI all lower healthy ranges and pointing up. Price has seen 3 days of higher high's / higher low's. Coming off of consolidating around Fib 0 / 0.631c and all time lows. The quick!! review I've done so far seems to be positive news, history of insider buying and looking good for a short squeeze. If it moves up in the morning I'll enter and base position size on volume. Ideally I'd like to establish a base position at current levels then add if its up over 10-20% on high volume.
DRIO - weekly frameEarning after the close on 3/21/22...expecting short term bear move near 5.60 with possible long term bull
DarioHealth Announces Three New Contracts as Growth Continues toDRIO: DarioHealth Corp.
2021-11-11 06:40:00
DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets
DRIO. Stay above 26.20, can Test 32 and run to ATH againLong DRIO, Small Cap.
Stop at 26.20 (Close Price Only)
Potentially look to add over 32
TDOC, enters Downtrend as Momentum drops below 0 level on Feb 22This indicator may be signaling that TDOC's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 82 similar cases where TDOC's Momentum Indicator fell below the 0 level, and 67 of them led to a successful outcome. Odds of Success: 82%. Current price $249.88 crossed the support line at $263.00 and is trading between $263.00 support and $227.21 support lines. Throughout the month of 01/20/21 - 02/22/21, the price experienced a +9% Uptrend, while the week of 02/12/21 - 02/22/21 shows a -8% Downtrend.
Bearish Trend Analysis
The 10-day RSI Indicator for TDOC moved out of overbought territory on February 11, 2021. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 58 similar instances where the indicator moved out of overbought territory. In 38 of the 58 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Moving Average Convergence Divergence Histogram (MACD) for TDOC turned negative on February 16, 2021. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 37 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TDOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
TDOC broke above its upper Bollinger Band on January 22, 2021. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
DRIO, MACD Histogram just turned negativeThis is a Bearish indicator signaling DRIO's price could decline from here. Traders may explore shorting the stock or put options. Tickeron's A.I.dvisor identified 51 similar cases where DRIO's MACD histogram became negative, and 42 of them led to successful outcomes. Odds of Success: 82%. Current price $27.65 is above $20.20 the highest resistance line found by Tickeron A.I. Throughout the month of 01/15/21 - 02/18/21, the price experienced a +51% Uptrend, while the week of 02/10/21 - 02/18/21 shows a -7% Downtrend.
Bearish Trend Analysis
The Stochastic Indicator may be shifting from an upward trend to a downward trend. Tickeron A.I. detetcted that in 36 of 39 cases where DRIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for DRIO turned negative on February 18, 2021. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 42 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
DRIO broke above its upper Bollinger Band on February 08, 2021. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Announces $28.6 Million Private PlacementDarioHealth Announces $28.6 Million Private Placement
closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel
pre-funded warrants to purchase 824,689 shares of common stock at an exercise price of $0.0001 per share. The purchase price per share was equal to $7.47, or the "Minimum Price," pursuant to Nasdaq Rule 5635(d) as of July 28, 2020, and the purchase price of each pre-funded warrant was $7.4699.
The adoption rate of digital therapeutics has been accelerated by the current pandemic.
www.prnewswire.com
Twitter:
Ben Rabizadeh
$DRIO HUGE bullish raise $29M in financing now positions them to grow rapidly in the $OTRK $LVGO $TDOC telehealth space! 🚀
This was not a bad offering out of desperation but rather a good offering to fuel the increased demand.
Insider buying-sec fillings 4k
DarioHealth Corp. Breakout watch DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.
pennies to thousands new stock candidategood volume new stock no overhead supply
relative strength good
upper bands on cci and percent r
money supply increasing
candle had wick wait for good opening candle see our book on amazon for entry rules
